FIELD: biotechnology.
SUBSTANCE: invention relates to using of lipopherol-liposomal preparation of antioxidant action for intravenous administration as protective medium. Said lipopherol contains soy psospholipids, DL-alpha-tocopherol, sorbitol-phosphate buffer. Protective medium of present invention prevents infection of bovine spongiform encephalopathy.
EFFECT: bioactive vaccines of high quality and immunity.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO OBTAIN COMBINED VACCINE AGAINST NEWCASTLE DISEASE AND INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 1993 |
|
RU2106152C1 |
| A DRY ASSOCIATED CULTURE VIRUS VACCINE AGAINST AVIAN NEWCASTLE DISEASE AND SMALLPOX | 2005 |
|
RU2295357C1 |
| AGENT FOR PROPHYLAXIS OF INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 1998 |
|
RU2138290C1 |
| VACCINE AGAINST NEWCASTLE DISEASE | 2007 |
|
RU2347584C1 |
| METHOD FOR MANUFACTURING VACCINE AGAINST INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 2003 |
|
RU2246317C1 |
| VIRUS-VACCINE AGAINST INFECTIOUS LARYNGOTRACHEITIS IN POULTRY FOR PERORAL INTAKE | 2000 |
|
RU2178308C1 |
| DRY LIVE VACCINE AGAINST NEWCASTLE DISEASE AND METHOD OF ITS PREPARING | 2000 |
|
RU2162341C1 |
| VIRUS VACCINE AGAINST INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 2002 |
|
RU2214277C1 |
| VIRUS VACCINE AGAINST NEWCASTLE BIRD DISEASE | 2004 |
|
RU2259844C1 |
| NEWCASTLE DISEASE VIRUS "VNIIZZH G7" STRAIN FOR PRODUCTION OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF NEWCASTLE DISEASE OF BIRDS | 2024 |
|
RU2821028C1 |
